SCHEMBL8636185

SCHEMBL8636185

Cc1ncoc1C(O)c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.43
ATM Q13315 2/20 0.40
KMT2A Q03164 1/20 0.40
CREBBP Q92793 1/20 0.38
AOC3 Q16853 1/20 0.33
AR P10275 1/20 0.33
NR3C1 P04150 1/20 0.33
NOTUM Q6P988 1/20 0.33
MAPK14 Q16539 1/20 0.31
GPR55 Q9Y2T6 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
JAK2 O60674 3/20 0.30
CYP3A4 P08684 3/20 0.30
CYP2C8 P10632 3/20 0.30
CYP2C9 P11712 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9026125 0.88 BRD4 (0.36) BRD4ATMKMT2ACREBBP
SCHEMBL8633722 0.86 BRD4 (0.41) BRD4KMT2ACREBBPNOTUMALDH1A1
SCHEMBL8630595 0.78 CES2 (0.38) BRD4CREBBP
SCHEMBL8629576 0.74 BRD4 (0.44) BRD4NOTUMALDH1A1MAPTMAPK1
SCHEMBL8634032 0.74 IMPDH2 (0.39) BRD4CREBBPALDH1A1MAPTMAPK1
SCHEMBL9026465 0.72 ALDH1A1 (0.39) BRD4CREBBPALDH1A1MAPTMAPK1
SCHEMBL8634779 0.71 KMT2A (0.38) KMT2AALDH1A1MAPTMAPK1SMN1; SMN2
SCHEMBL8632301 0.70 GAA (0.44) BRD4ALDH1A1MAPTMAPK1SMN1; SMN2
SCHEMBL8632971 0.69 NOTUM (0.38) KMT2ANOTUMMAPTSMN1; SMN2
SCHEMBL597442 0.69 IDO1 (0.46) BRD4ATMKMT2AAOC3NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1047169-C (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives ASTRA AB (SE) 1999-12-08 CN claimed
US-5712299-A TREATMENT OF NEURODEGENERATIVE DISORDERS ASTRA AKTIEBOLAG (SE) 1998-01-27 US claimed
CN-1126991-A Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives ASTRA AB (SE) 1996-07-17 CN claimed
EP-0707574-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES Astra Aktiebolag (SE) 1996-04-24 EP claimed
WO-1995001968-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1995-01-19 WO claimed
CN-1047169-C (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives ASTRA AB (SE) 1999-12-08 CN disclosed
US-5712299-A TREATMENT OF NEURODEGENERATIVE DISORDERS ASTRA AKTIEBOLAG (SE) 1998-01-27 US disclosed
CN-1126991-A Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives ASTRA AB (SE) 1996-07-17 CN disclosed
EP-0707574-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES Astra Aktiebolag (SE) 1996-04-24 EP disclosed
WO-1995001968-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1995-01-19 WO disclosed